Storage of biospecimens and associated services in support of nhanes.

Ended Awarded Last action

Contract number
75D30125F00215
Awardee
Awarding agency
Obligated
$159,463

Award facts

Contract value 46% obligated
  • $159,463.00 Current, with exercised options
  • $344,435.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
621511 Medical Laboratories
PSC
Q999 Medical- Other
Set-aside
No set-aside
Competition
Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Frederick, MD 21702, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a delivery order valued at $344,435 to Srisai Biopharmaceutical Solutions LLC for the storage of biospecimens and associated services in support of the National Health and Nutrition Examination Survey (NHANES) program. The contract, which is firm fixed price with no set-aside designation, is scheduled for completion by March 14, 2026, with performance taking place in Frederick, Maryland. Srisai Biopharmaceutical Solutions LLC is a small disadvantaged business specializing in biospecimen storage and management for federal research agencies, particularly those focused on public health and medical research.

This delivery order falls under Srisai's existing Indefinite Delivery Contract with CDC Pittsburgh, which is valued at approximately $2.6 million through March 2030 and is set aside for small businesses. The larger IDC supports NHANES by providing comprehensive biospecimen storage services, including receiving, storing, maintaining, and shipping approximately 500,000 biological samples. The contractor's services encompass cryogenic freezer storage and management, inventory control, sample handling, and disposal services, providing critical infrastructure support for the CDC's ongoing public health research and nutritional surveillance initiatives.

Quick answers

Who was awarded contract 75D30125F00215?

75D30125F00215 was awarded to Srisai Biopharmaceutical Solutions LLC by CDC Pittsburgh (Centers for Disease Control and Prevention) on March 15, 2025.

How much is contract 75D30125F00215 worth?

The government has obligated $159,463 on 75D30125F00215. Its potential value, with all options, is $344,435.

Is contract 75D30125F00215 an order under another contract?

Yes. 75D30125F00215 is a delivery order under 75D30125D00208, an indefinite delivery contract.

Was contract 75D30125F00215 competed?

The extent of competition for 75D30125F00215 was competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award